drugset / Trial / NCT03778242

Tranexamic Acid in Pregnant Women Undergoing Cesarean Section.

NCT03778242

Completed 180 enrolled Aswan University Hospital
RandomizedParallel-groupOpen-labelPrevention

Summary

Purpose to evaluate the effects of topical tranexamic acid (TA) on reducing post-partum hemorrhage in pregnant women with hemorrhagic cesarean section

Timeline

Start
2019-01-01
Primary completion
2022-03-30
Completion
2022-07-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tranexamic Acid Small molecule 2 g Topical

Indications

No indication recorded.